José Carlos F Galduróz

Prof. José Carlos F Galduróz

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2013 in Geriatrics & Gerontology International
Verified
Journal Article
Closed access
PDF file
LFLeandro Ferreira
Leandro Ferreira
RSRuth Ferreira Santos‐Galduróz
Ruth Ferreira Santos‐Galduróz
CFCleusa Pinheiro Ferri
Cleusa Pinheiro Ferri
JGJosé Carlos F Galduróz
José Carlos F Galduróz

21 December 2015 in Geriatrics & Gerontology International
Verified
Journal Article
Closed access
PDF file
MDMarcelo Ad Danucalov
Marcelo Ad Danucalov
EKElisa Harumi Kozasa
Elisa Harumi Kozasa
RARui F Afonso
Rui F Afonso
JGJosé Carlos F Galduróz
José Carlos F Galduróz
JLJosé R Leite
José R Leite

1 January 2013 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
MDM. A. D. Danucalov
M. A. D. Danucalov
EKElisa Harumi Kozasa
Elisa Harumi Kozasa
KRK. T. Ribas
K. T. Ribas
JGJosé Carlos F Galduróz
José Carlos F Galduróz
MGM. C. Garcia
M. C. Garcia
JLJ. R. Leite
J. R. Leite
Familial caregivers of patients with Alzheimer's disease exhibit reduced quality of life and increased stress levels. The aim of this study was to investigate the effects of an 8-week yoga and compassion meditation program on the perceived stress, anxiety, depression, and salivary cortisol levels in familial caregivers. A total of 46 volunteers were randomly assigned to participate in a stress-reduction program for a 2-month period (yoga and compassion meditation program—YCMP group) (n=25) or an untreated group for the same period of time (control group) (n=21). The levels of stress, anxiety, depression, and morning salivary cortisol of the participants were measured before and after intervention. The groups were initially homogeneous; however, after intervention, the groups diverged significantly. The YCMP group exhibited a reduction of the stress (P<0.05), anxiety (P<0.000001), and depression (P<0.00001) levels, as well as a reduction in the concentration of salivary cortisol (P<0.05). Our study suggests that an 8-week yoga and compassion meditation program may offer an effective intervention for reducing perceived stress, anxiety, depression, and salivary cortisol in familial caregivers.

1 March 2005 in Addictive Behaviors
Verified
Journal Article
Closed access
JGJosé Carlos F Galduróz
José Carlos F Galduróz
ANAna Regina Noto
Ana Regina Noto
SNSolange A. Nappo
Solange A. Nappo
ECE.A. Carlini
E.A. Carlini

1 July 2003 in Pharmacopsychiatry
Verified
Journal Article
Closed access
PDF file
RSR. F. Santos
R. F. Santos
JGJosé Carlos F Galduróz
José Carlos F Galduróz
ABA. Barbieri
A. Barbieri
MCM. L. V. Castiglioni
M. L. V. Castiglioni
LYL. Y. Ytaya
L. Y. Ytaya
OBO. F. A. Bueno
O. F. A. Bueno
The aging process is associated with several cognitive alterations. This study looks at the effects of taking dried extract of Ginkgo biloba, which has been used in several countries in an attempt to minimize these effects. The subjects were 48 men aged 60 - 70 matched between control and experimental groups for educational level. Evaluation was based on a number of neuropsychological tests in an attempt to cover the largest possible number of functions including Single Photon Emission Computer Tomography (SPECT) and measures of blood viscosity. The study was run on a double-blind basis with placebo and Ginkgo biloba groups evaluated over a period of 8 months. After treatment, the experimental group showed a reduction in blood viscosity, improved cerebral perfusion in specific areas and improved global cognitive functioning. The control group showed the opposite - higher blood viscosity, a reduction in cerebral perfusion (in specific areas), and cognitive deterioration in different functions. Although the mechanisms by which Ginkgo biloba may contribute to overall enhancement of the parameters evaluated have not been specified, this plant extract certainly appears to be effective in the treatment of cognitive deficits in older people. Further research into its use is called for on the basis of the results obtained here.

10 November 2015 in Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
IMInge Mick
Inge Mick
JMJim Myers
Jim Myers
ARAnna C Ramos
Anna C Ramos
PSPaul R A Stokes
Paul R A Stokes
DEDavid Erritzoe
David Erritzoe
ALAnne R Lingford-Hughes
Anne R Lingford-Hughes
Pathological gambling is a psychiatric disorder and the first recognized behavioral addiction, with similarities to substance use disorders but without the confounding effects of drug-related brain changes. Pathophysiology within the opioid receptor system is increasingly recognized in substance dependence, with higher mu-opioid receptor (MOR) availability reported in alcohol, cocaine and opiate addiction. Impulsivity, a risk factor across the addictions, has also been found to be associated with higher MOR availability. The aim of this study was to characterize baseline MOR availability and endogenous opioid release in pathological gamblers (PG) using [11C]carfentanil PET with an oral amphetamine challenge. Fourteen PG and 15 healthy volunteers (HV) underwent two [11C]carfentanil PET scans, before and after an oral administration of 0.5 mg/kg of d-amphetamine. The change in [11C]carfentanil binding between baseline and post-amphetamine scans (ΔBPND) was assessed in 10 regions of interest (ROI). MOR availability did not differ between PG and HV groups. As seen previously, oral amphetamine challenge led to significant reductions in [11C]carfentanil BPND in 8/10 ROI in HV. PG demonstrated significant blunting of opioid release compared with HV. PG also showed blunted amphetamine-induced euphoria and alertness compared with HV. Exploratory analysis revealed that impulsivity positively correlated with caudate baseline BPND in PG only. This study provides the first evidence of blunted endogenous opioid release in PG. Our findings are consistent with growing evidence that dysregulation of endogenous opioids may have an important role in the pathophysiology of addictions.